Australia's most trusted
source of pharma news
Posted 16 January 2025 PM
Two years after leaving Australia, Jeppe Theisen's star continues to rise at Novo Nordisk with the former Aussie General Manager clocking up another promotion, taking the role of Corporate Vice President, Business Area North & Central.
It's a significant role given Novo Nordisk is now one of the biggest pharmaceutical companies on the planet, thanks to its burgeoning semaglutide franchise which includes diabetes drug Ozempic and obesity treatment Wegovy. It expands his leadership territory to six countries - Denmark, Iceland, Switzerland, Norway, Sweden and Finland.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.